GlassScriptPhysician profile
Anupama Sunkavalli
NPI 1669676375
$4,059.76
in general payments reported to CMS, 2019-2025
32 companies · $744 in 2025
The $744 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $122 · 2021: $272 · 2022: $823 · 2023: $904 · 2024: $776 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,424.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $435.35 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $422.15 | 2023-2025 | Myfembree, Gemtesa |
| Daiichi Sankyo INC. | $417.80 | 2021-2024 | Injectafer |
| Exeltis, USA INC. | $372.88 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $289.77 | 2021-2025 | |
| Astellas Pharma US INC | $270.25 | 2022-2025 | Veozah, Vesicare |
| Amgen INC. | $233.79 | 2019-2025 | Evenity, Prolia |
| Hologic Sales and Service, LLC | $201.86 | 2019-2024 | Aptima, Myosure Tissue Removal Device, Acessa Provu System |
| Myovant Sciences INC. | $139.05 | 2021-2022 | |
| Sage Therapeutics, LLC | $127.98 | 2024-2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $125.00 | 2025 | Qelbree |
| Silk Road Medical, INC. | $122.03 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Evofem Biosciences, INC. | $87.34 | 2022-2025 | Solosec, Phexx, Phexxi |
| Roche Diagnostics Corporation | $74.60 | 2019-2021 | |
| Avion Pharmaceuticals | $69.51 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $69.02 | 2023-2025 | Nexplanon, Jada System |
| Amag Pharmaceuticals, INC. | $61.93 | 2019 | |
| Millicent US INC | $59.50 | 2019-2025 | Femlyv, Intrarosa |
| Exact Sciences Corporation | $58.81 | 2023-2025 | Cologuard Collection Kit |
| Radius Health, INC. | $56.79 | 2022-2023 | |
| Lupin INC. | $52.07 | 2019-2020 | |
| Pfizer INC. | $50.92 | 2024 | |
| Medtronic, INC. | $48.61 | 2021-2022 | |
| Therapeuticsmd, INC. | $43.32 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.65 | 2019-2025 | |
| Agile Therapeutics, INC. | $29.11 | 2022-2023 | Twirla |
| Allergan, INC. | $25.24 | 2019 | |
| Smith+Nephew, INC. | $18.32 | 2024 | Pico 7 |
| Si-Bone, INC. | $15.79 | 2021 | |
| Alydia Health | $14.79 | 2021 | |
| Merck Sharp & Dohme LLC | $14.64 | 2019 | |
| Coopersurgical, INC. | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anupama Sunkavalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.